Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium

R. Wang, I. K. Kwon, Nagendra Singh, B. Islam, Kebin Liu, Subbaramiah Sridhar, F. Hofmann, Darren D Browning

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Analysis of knockout animals indicates that 3′,5′cyclic guanosine monophosphate (cGMP) has an important role in gut homeostasis but the signaling mechanism is not known. The goals of this study were to test whether increasing cGMP could affect colon homeostasis and determine the mechanism. We increased cGMP in the gut of Prkg2 +/+ and Prkg2 -/- mice by treating with the PDE5 inhibitor Vardenafil (IP). Proliferation, differentiation and apoptosis in the colon mucosa were then quantitated. Vardenafil (Vard) treatment increased cGMP in colon mucosa of all mice, but reduced proliferation and apoptosis, and increased differentiation only in Prkg2 +/+ mice. Vard and cGMP treatment also increased dual specificity protein phosphatase 10 (DUSP10) expression and reduced phospho-c-Jun N-terminal kinase (JNK) levels in the colon mucosa of Prkg2 +/+ but not Prkg2 -/- mice. Treatment of Prkg2 -/- mice with the JNK inhibitor SP600125 reversed the defective homeostasis observed in these animals. Activation of protein kinase G2 (PKG2) in goblet-like LS174T cells increased DUSP10 expression and reduced JNK activity. PKG2 also increased goblet cell-specific MUC2 expression in LS174T cells, and this process was blocked by DUSP10-specific siRNA. The ability of cGMP signaling to inhibit JNK-induced apoptosis in vivo was demonstrated using dextran sodium sulfate (DSS) to stress the colon epithelium. Vard was a potent inhibitor of DSS-induced epithelial apoptosis, and significantly blocked pathological endpoints in this model of experimental colitis. In conclusion, Vard treatment activates cGMP signaling in the colon epithelium. Increased PKG2 activity alters homeostasis by suppressing proliferation and apoptosis while promoting differentiation. The PKG2-dependent mechanism was shown to involve increased DUSP10 and subsequent inhibition of JNK activity.

Original languageEnglish (US)
Pages (from-to)427-437
Number of pages11
JournalCell Death and Differentiation
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Cyclic GMP-Dependent Protein Kinase Type II
JNK Mitogen-Activated Protein Kinases
Dual-Specificity Phosphatases
Colon
Homeostasis
Epithelium
Phosphoprotein Phosphatases
Protein Kinases
Apoptosis
Dextran Sulfate
Mucous Membrane
Phosphodiesterase 5 Inhibitors
Goblet Cells
Colitis
Small Interfering RNA
Theoretical Models
Vardenafil Dihydrochloride

Keywords

  • DUSP10
  • JNK
  • PKG2
  • cGMP
  • colon

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium. / Wang, R.; Kwon, I. K.; Singh, Nagendra; Islam, B.; Liu, Kebin; Sridhar, Subbaramiah; Hofmann, F.; Browning, Darren D.

In: Cell Death and Differentiation, Vol. 21, No. 3, 01.03.2014, p. 427-437.

Research output: Contribution to journalArticle

@article{221cc39dec624122a08f6f347128e981,
title = "Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium",
abstract = "Analysis of knockout animals indicates that 3′,5′cyclic guanosine monophosphate (cGMP) has an important role in gut homeostasis but the signaling mechanism is not known. The goals of this study were to test whether increasing cGMP could affect colon homeostasis and determine the mechanism. We increased cGMP in the gut of Prkg2 +/+ and Prkg2 -/- mice by treating with the PDE5 inhibitor Vardenafil (IP). Proliferation, differentiation and apoptosis in the colon mucosa were then quantitated. Vardenafil (Vard) treatment increased cGMP in colon mucosa of all mice, but reduced proliferation and apoptosis, and increased differentiation only in Prkg2 +/+ mice. Vard and cGMP treatment also increased dual specificity protein phosphatase 10 (DUSP10) expression and reduced phospho-c-Jun N-terminal kinase (JNK) levels in the colon mucosa of Prkg2 +/+ but not Prkg2 -/- mice. Treatment of Prkg2 -/- mice with the JNK inhibitor SP600125 reversed the defective homeostasis observed in these animals. Activation of protein kinase G2 (PKG2) in goblet-like LS174T cells increased DUSP10 expression and reduced JNK activity. PKG2 also increased goblet cell-specific MUC2 expression in LS174T cells, and this process was blocked by DUSP10-specific siRNA. The ability of cGMP signaling to inhibit JNK-induced apoptosis in vivo was demonstrated using dextran sodium sulfate (DSS) to stress the colon epithelium. Vard was a potent inhibitor of DSS-induced epithelial apoptosis, and significantly blocked pathological endpoints in this model of experimental colitis. In conclusion, Vard treatment activates cGMP signaling in the colon epithelium. Increased PKG2 activity alters homeostasis by suppressing proliferation and apoptosis while promoting differentiation. The PKG2-dependent mechanism was shown to involve increased DUSP10 and subsequent inhibition of JNK activity.",
keywords = "DUSP10, JNK, PKG2, cGMP, colon",
author = "R. Wang and Kwon, {I. K.} and Nagendra Singh and B. Islam and Kebin Liu and Subbaramiah Sridhar and F. Hofmann and Browning, {Darren D}",
year = "2014",
month = "3",
day = "1",
doi = "10.1038/cdd.2013.163",
language = "English (US)",
volume = "21",
pages = "427--437",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium

AU - Wang, R.

AU - Kwon, I. K.

AU - Singh, Nagendra

AU - Islam, B.

AU - Liu, Kebin

AU - Sridhar, Subbaramiah

AU - Hofmann, F.

AU - Browning, Darren D

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Analysis of knockout animals indicates that 3′,5′cyclic guanosine monophosphate (cGMP) has an important role in gut homeostasis but the signaling mechanism is not known. The goals of this study were to test whether increasing cGMP could affect colon homeostasis and determine the mechanism. We increased cGMP in the gut of Prkg2 +/+ and Prkg2 -/- mice by treating with the PDE5 inhibitor Vardenafil (IP). Proliferation, differentiation and apoptosis in the colon mucosa were then quantitated. Vardenafil (Vard) treatment increased cGMP in colon mucosa of all mice, but reduced proliferation and apoptosis, and increased differentiation only in Prkg2 +/+ mice. Vard and cGMP treatment also increased dual specificity protein phosphatase 10 (DUSP10) expression and reduced phospho-c-Jun N-terminal kinase (JNK) levels in the colon mucosa of Prkg2 +/+ but not Prkg2 -/- mice. Treatment of Prkg2 -/- mice with the JNK inhibitor SP600125 reversed the defective homeostasis observed in these animals. Activation of protein kinase G2 (PKG2) in goblet-like LS174T cells increased DUSP10 expression and reduced JNK activity. PKG2 also increased goblet cell-specific MUC2 expression in LS174T cells, and this process was blocked by DUSP10-specific siRNA. The ability of cGMP signaling to inhibit JNK-induced apoptosis in vivo was demonstrated using dextran sodium sulfate (DSS) to stress the colon epithelium. Vard was a potent inhibitor of DSS-induced epithelial apoptosis, and significantly blocked pathological endpoints in this model of experimental colitis. In conclusion, Vard treatment activates cGMP signaling in the colon epithelium. Increased PKG2 activity alters homeostasis by suppressing proliferation and apoptosis while promoting differentiation. The PKG2-dependent mechanism was shown to involve increased DUSP10 and subsequent inhibition of JNK activity.

AB - Analysis of knockout animals indicates that 3′,5′cyclic guanosine monophosphate (cGMP) has an important role in gut homeostasis but the signaling mechanism is not known. The goals of this study were to test whether increasing cGMP could affect colon homeostasis and determine the mechanism. We increased cGMP in the gut of Prkg2 +/+ and Prkg2 -/- mice by treating with the PDE5 inhibitor Vardenafil (IP). Proliferation, differentiation and apoptosis in the colon mucosa were then quantitated. Vardenafil (Vard) treatment increased cGMP in colon mucosa of all mice, but reduced proliferation and apoptosis, and increased differentiation only in Prkg2 +/+ mice. Vard and cGMP treatment also increased dual specificity protein phosphatase 10 (DUSP10) expression and reduced phospho-c-Jun N-terminal kinase (JNK) levels in the colon mucosa of Prkg2 +/+ but not Prkg2 -/- mice. Treatment of Prkg2 -/- mice with the JNK inhibitor SP600125 reversed the defective homeostasis observed in these animals. Activation of protein kinase G2 (PKG2) in goblet-like LS174T cells increased DUSP10 expression and reduced JNK activity. PKG2 also increased goblet cell-specific MUC2 expression in LS174T cells, and this process was blocked by DUSP10-specific siRNA. The ability of cGMP signaling to inhibit JNK-induced apoptosis in vivo was demonstrated using dextran sodium sulfate (DSS) to stress the colon epithelium. Vard was a potent inhibitor of DSS-induced epithelial apoptosis, and significantly blocked pathological endpoints in this model of experimental colitis. In conclusion, Vard treatment activates cGMP signaling in the colon epithelium. Increased PKG2 activity alters homeostasis by suppressing proliferation and apoptosis while promoting differentiation. The PKG2-dependent mechanism was shown to involve increased DUSP10 and subsequent inhibition of JNK activity.

KW - DUSP10

KW - JNK

KW - PKG2

KW - cGMP

KW - colon

UR - http://www.scopus.com/inward/record.url?scp=84893824487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893824487&partnerID=8YFLogxK

U2 - 10.1038/cdd.2013.163

DO - 10.1038/cdd.2013.163

M3 - Article

C2 - 24270408

AN - SCOPUS:84893824487

VL - 21

SP - 427

EP - 437

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 3

ER -